INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB. Mediterr J Hematol Infect Dis 2018, 10 (1), e2018029. https://doi.org/10.4084/mjhid.2018.029.